Back
ProShares UltraShort Nasdaq Biotechnology Vs. ACM Research, Inc. Industry Stock Comparison
Sell
27
BIS
ProShares UltraShort Nasdaq Biotechnology
Last Price:
$8.91
Seasonality Move:
-7.3%
Sell
20
ACMR
ACM Research, Inc.
Last Price:
$40.52
Seasonality Move:
13.68%
Sell
27
ProShares UltraShort Nasdaq Biotechnology (BIS)
is a Sell
Is ProShares UltraShort Nasdaq Biotechnology a Buy, Sell or Hold?
-
The current ProShares UltraShort Nasdaq Biotechnology [BIS] share price is $8.77. The Score for BIS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
BIS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
ACM Research, Inc. (ACMR)
is a Sell
Is ACM Research, Inc. a Buy, Sell or Hold?
-
The current ACM Research, Inc. [ACMR] share price is $40.54. The Score for ACMR is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
ACMR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
BIS Stock Price Chart
What is ProShares UltraShort Nasdaq Biotechnology's stock price today?
-
The ProShares UltraShort Nasdaq Biotechnology share price today is $8.77Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing slight selling pressure.
ACMR Stock Price Chart
What is ACM Research, Inc.'s stock price today?
-
The ACM Research, Inc. share price today is $40.54Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACMR is experiencing slight buying pressure.
BIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 44.5 | Sell |
| Chaikin Money Flow: | -1577 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.71 - 9.55) | Sell |
| Bollinger Bands (100): | (8.68 - 9.8) | Sell |
ACMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.8 | Sell |
| Relative Strength Index (14 RSI): | 36.1 | Sell |
| Chaikin Money Flow: | 278577 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.39 - 50.65) | Sell |
| Bollinger Bands (100): | (35.52 - 57.1) | Sell |
BIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.26 | Sell |
| 20-day SMA: | 9.24 | Sell |
| 50-day SMA: | 8.9 | Sell |
| 200-day SMA: | 11.76 | Sell |
| 8-day EMA: | 9.12 | Sell |
| 20-day EMA: | 9.16 | Sell |
| 50-day EMA: | 9.14 | Sell |
| 200-day EMA: | 11.39 | Sell |
ACMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.39 | Sell |
| 20-day SMA: | 44.31 | Sell |
| 50-day SMA: | 53.34 | Sell |
| 200-day SMA: | 39.17 | Buy |
| 8-day EMA: | 41.31 | Sell |
| 20-day EMA: | 44.9 | Sell |
| 50-day EMA: | 48.48 | Sell |
| 200-day EMA: | 40.92 | Sell |
ProShares UltraShort Nasdaq Biotechnology Earnings Growth & BIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ACM Research, Inc. Earnings Growth & ACMR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.28 per share, an increase this year of $0.02 per share, and an increase next year of $0.49 per share.
ProShares UltraShort Nasdaq Biotechnology Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ACM Research, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||